Malaysia's Dengue Crisis Exposes Flawed Priorities in Healthcare The recent surge in dengue cases and subsequent deaths in Malaysia has highlighted a disturbing trend: despite having access to a vaccine, many Malaysians are still falling victim to the disease.
The government and health experts may blame vaccine hesitancy for the low uptake, but the reality is more complex.
One of the most glaring issues is the cost of the dengue vaccine, which ranges from 420 to 500 ringgit (US$104 to US$124) for a two dose regime.